Ocular Surface Disease Management in the Preoperative Cataract Patient
CME Activity Pricing
ASCRS Member Price: FREE
Nonmember Price: FREE
ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from Alcon Vision, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, and Santen.
Join us for this satellite program to hear about the impact of OSD on cataract and refractive surgical outcomes, the role of inflammation in OSD and options for anti-inflammatory therapies, and the role of lid margin disease in OSD. Hear from our expert faculty on these topics followed by additional real-world cases and live panel discussion covering important educational pearls.
Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
Duration: 60 minutes
Activity Expiration Date: August 31, 2022
|Marjan Farid, MD||Preeya Gupta, MD|
|Brandon Ayres, MD||Laura Periman, MD||Marguerite McDonald, MD|
- Recognize the impact of OSD on cataract and refractive surgical outcomes and discuss which diagnostic devices are most helpful in the preoperative setting.
- Define the role of inflammation in OSD and differentiate between options for anti-inflammatory therapies.
- Identify the role of lid margin disease in OSD and review various options for treatment.